| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
during pulmonary ischemia-reperfusion injuryDepartments of 1Surgery and 2Medicine, University of Virginia Health System, Charlottesville, Virginia
Submitted 7 December 2006 ; accepted in final form 4 April 2007
 |
ABSTRACT |
|---|
 TOP ABSTRACT MATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
and monocyte chemoattractant protein-1 (MCP-1) from macrophages are known to modulate acute IR injury, the contribution of alveolar epithelial cells to IR injury and their intercellular interactions with other cell types such as alveolar macrophages and neutrophils remain unclear. In this study, we tested the hypothesis that following IR, alveolar macrophage-produced TNF- further induces alveolar epithelial cells to produce key chemokines that could then contribute to subsequent lung injury through the recruitment of neutrophils. Cultured RAW264.7 macrophages and MLE-12 alveolar epithelial cells were subjected to acute hypoxia-reoxygenation (H/R) as an in vitro model of pulmonary IR. H/R (3 h/1 h) significantly induced KC, MCP-1, macrophage inflammatory protein-2 (MIP-2), RANTES, and IL-6 (but not TNF-) by MLE-12 cells, whereas H/R induced TNF-, MCP-1, RANTES, MIP-1, and MIP-2 (but not KC) by RAW264.7 cells. These results were confirmed using primary murine alveolar macrophages and primary alveolar type II cells. Importantly, using macrophage and epithelial coculture methods, the specific production of TNF- by H/R-exposed RAW264.7 cells significantly induced proinflammatory cytokine/chemokine expression (KC, MCP-1, MIP-2, RANTES, and IL-6) by MLE-12 cells. Collectively, these results demonstrate that alveolar type II cells, in conjunction with alveolar macrophage-produced TNF-, contribute to the initiation of acute pulmonary IR injury via a proinflammatory cascade. The release of key chemokines, such as KC and MIP-2, by activated type II cells may thus significantly contribute to neutrophil sequestration during IR injury. cytokines; chemokines
and monocyte chemoattractant protein-1 (MCP-1), respectively, are secreted early by alveolar macrophages after IR and are postulated to contribute to lung IR injury (10, 12, 13, 22). Depletion of alveolar macrophages dramatically reduces IR injury, lung dysfunction, and induction of cytokines/chemokines such as TNF-, macrophage inflammatory protein-2 (MIP-2), and MCP-1 (22). Work by Eppinger et al. (3) strengthens the role of alveolar macrophages in acute IR injury by demonstrating a requirement for TNF-, IFN-
, and MCP-1 through the use of specific neutralizing antibodies. One likely mechanism for decreased injury after cytokine neutralization is the suppression of macrophage function, since TNF- and IFN- are involved in respiratory burst activity and other inflammatory functions of macrophages (8, 13, 17). Together, these observations suggest that alveolar macrophages are activated early by IR and initiate a cascade of events leading to the activation of the recipient inflammatory system.
Although the central role of alveolar macrophages and neutrophils in IR injury is becoming better understood, the importance of other resident lung cell populations such as alveolar epithelial cells, and their cross talk with alveolar macrophages and neutrophils, remains unclear. There is increasing evidence suggesting that the alveolar epithelium, traditionally regarded as the target of an inflammatory response, may contribute significantly to the development and resolution of the inflammatory reaction (2). The proinflammatory role of type II epithelial cells via secretion of chemokines has been shown in other models of inflammatory lung injury (2, 20). The apparent parallels between lung IR injury and other forms of acute inflammatory injury point to the speculation that type II epithelial cells could significantly contribute to pulmonary IR injury. Synthesis of chemokines such as MCP-1 from pulmonary epithelial-like cells and its induction by macrophage-derived mediators such as TNF- have been demonstrated (19).
The current study focuses on the effect of IR-activated alveolar macrophages via TNF- on subsequent activation of alveolar epithelial cells. We hypothesized that following IR, alveolar macrophage-produced TNF- further activates alveolar epithelial cells to subsequently produce key chemokines that could lead to neutrophil recruitment and lung injury. To specifically focus on alveolar macrophages and epithelial cells, we utilized an in vitro model encompassing a murine macrophage cell line, RAW264.7, and a murine alveolar type II epithelial cell line, MLE-12. These cells were exposed to periods of acute hypoxia and reoxygenation (H/R) to model in vivo lung IR injury. H/R resulted in the induction of proinflammatory cytokines and chemokines by alveolar macrophages as well as epithelial cells. Moreover, macrophage-derived TNF- was found to specifically augment chemokine induction by alveolar epithelial cells demonstrating that 1) epithelial cells produce specific proinflammatory chemokines and 2) a cross talk exists between alveolar macrophages and epithelial cells via TNF- following IR injury. These events likely result in enhanced neutrophil recruitment and activation, thereby further exacerbating pulmonary IR injury.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
was purchased from R&D Systems (Minneapolis, MN). Anti-TNF- antibody was purchased from Calbiochem (San Diego, CA). The murine macrophage (RAW264.7) and alveolar type II epithelial (MLE-12) cell lines were obtained from American Type Culture Collection (Manassas, VA). Cell culture components were obtained as follows: matrigel and rat tail collagen was from BD Biosciences (Franklin Lakes, NJ); keratinocyte growth factor was from Peprotech (Rocky Hill, NJ); and bronchial epithelial cell growth medium was from Clonetics (Walkersville, MD). Animals. For the purpose of isolating primary alveolar epithelial cells and alveolar macrophages, we utilized 6-wk-old male C57BL/6 and Swiss-Webster mice, respectively (The Jackson Laboratory, Bar Harbor, ME). Animal acquisition and use was under the supervision of the Center for Comparative Medicine and a licensed veterinarian. All animals received humane care in compliance with the "Principles of Laboratory Animal Care," formulated by the National Society for Medical Research, and "The Guide for the Care and Use of Laboratory Animals," prepared by the National Academy of Science and published by the National Institutes of Health. The animal protocol was approved by the Institutional Animal Care and Use Committee.
Cell culture.
RAW264.7 cells were grown in complete medium consisting of DMEM with 4.5 g/l glucose containing 10% FBS and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA) at 37°C in a humidified atmosphere of 5% CO2 and 95% O2. MLE-12 cells were grown in DMEM with 15 mM HEPES under similar conditions as described above. For exposure to H/R, culture dishes were placed in a humidified, sealed hypoxic chamber (Billups-Rothenberg, Del Mar, CA) that was purged with 95% N2 and 5% CO2 for 25 min to establish hypoxia. The chamber was then placed in a cell culture incubator for the desired time period after which it was opened and the culture media was immediately analyzed for O2 concentration using a blood-gas analyzer (Chiron Diagnostics). Reoxygenation was achieved by removing the plates from the hypoxic chamber and placing them in a normoxic, humidified incubator (37°C, 5% CO2 and 95% O2) for 1 h. The partial percentage of O2 in the culture media after hypoxia exposure was consistently found to be 5% compared with the normoxic PO2, which was 21%. The culture media reached atmospheric PO2 (21%) within 5 min of removal from the hypoxic chamber. All experiments (both normoxic and hypoxic) were performed at 37°C. Pretreatment of RAW264.7 cells with anti-TNF--neutralizing antibody (1 µg/ml) was done 1 h before the hypoxic induction, wherever indicated. The optimum dose for anti-TNF- antibody (1 µg/ml) was selected based on a dose-response experiment wherein the selected dose completely inhibited TNF-.
Coculture experiments.
MLE-12 cells were cultured in a 12-well culture plate (5 x 105 cells/well) on a Transwell membrane insert (Corning Costar), and RAW264.7 cells (5 x 105 cells/well) were cultured in a 12-well plate. After normoxia (4 h) or H/R (3 h/1 h), the MLE-12 culture insert was washed once with PBS and placed into the well containing the H/R-activated RAW264.7 cells (with or without anti-TNF--neutralizing antibody) for an additional 4-h period. MLE-12 and RAW264.7 cells were also exposed simultaneously (in the same wells) to H/R for 3 h/1 h with or without anti-TNF--neutralizing antibody. Conversely, H/R-activated (3 h/1 h) epithelial cells on Transwell inserts (and accompanying media) were placed into wells containing normoxic macrophages (prewashed with PBS) for 4 h. For the mixed cocultures, MLE-12 and RAW264.7 cells were cultured together (in the same monolayer) in a 12-well plate at a density of 2.5 x 105 cells (of each cell type) per well for 15 h and washed once with PBS before being subjected to either normoxia (4 h) or H/R (3 h/1 h). The culture media was then collected and analyzed for cytokine/chemokine analysis as described below.
Cytokine and chemokine protein analysis. Cell culture media was collected and centrifuged at 1, 000 g for 2 min, and the supernatant was frozen at –80°C. The cytokine and chemokine protein content was quantified using the Bioplex Bead Array technique using a multiplex cytokine panel assay (Bio-Rad Laboratories, Hercules, CA). The samples were analyzed as instructed by the Bioplex array reader, which is a fluorescent-based flow cytometer employing a bead-based multiplex technology, each of which is conjugated with a reactant specific for a different target molecule.
Isolation and culture of primary alveolar type II cells. Alveolar type II cells were isolated from 6-wk-old C57BL/6 mice and cultured as described by Rice et al. (18). Mice were anesthetized with ketamine and xylazine and exsanguinated, and the trachea was isolated and cannulated. The diaphragm was cut, and the sternum and thymus were removed. A 21-gauge needle with a 10-ml syringe was used to perfuse the lungs via the pulmonary artery with 0.9% saline. Dispase (1 ml) was rapidly instilled through the tracheal cannula and was followed by 1 ml of agarose, after which the lungs were covered with ice for 2 min to gel the agarose. Lungs were harvested and placed in 1 ml of dispase at room temperature for 45 min. Subsequently, lungs were transferred to a 60-mm culture dish containing 7 ml of HEPES-buffered DMEM and 100 U/ml DNase I, and lung tissue was gently teased from the bronchi. The cell suspension was filtered through two cell strainers (100 µm followed by 40 µm) and centrifuged at 130 g for 8 min at 4°C and placed on prewashed 100-mm culture dishes that had been coated for 24 h at 4°C with 42 µg of anti-CD45 and 16 µg of anti-CD32 antibodies (BD Biosciences, San Jose, CA) in PBS. After incubation for 1 h at 37°C, type II cells were collected by centrifugation and resuspended in DMEM + 5% charcoal-stripped FBS and keratinocyte growth factor (10 ng/ml). Cells were plated at a density of 5 x 105 per 25-mm culture dish coated with 70% matrigel and 30% rat tail collagen. Cells were cultured for 5 days before being used for the experiments. With the use of this technique, the purity of isolated type II cells was >95% as determined by immunostaining for prosurfactant protein C using pro-SP-C antibody (Chemicon International, Billerica, MA).
Isolation and culture of primary alveolar macrophages.
Primary alveolar macrophages were isolated from the bronchoalveolar lavage (BAL) fluid of 6-wk-old Swiss-Webster mice and subsequently cultured. Briefly, the mice were anesthetized with ketamine and xylazine and exsanguinated, and the trachea was isolated and cannulated. The lungs were then perfused three times with 1 ml of PBS, and the BAL fluid was retrieved. For each experiment, BAL fluid from three to five mice was pooled and centrifuged at 330 g for 10 min, and the pellet was resuspended in DMEM containing 10% FBS. The cells were plated on 25-mm culture dishes (5 x 105 cells/dish) and incubated at 37°C overnight before being used for the experiments. Differential cell counts of BAL fluid using Diff-Quik (Baxter Healthcare, Compton, UK) demonstrated 
97% pure population of alveolar macrophages.
Statistical analysis. All experiments were performed with n = 5. Values are presented as means ± SEM. Statistical significance was determined using a two-tailed Student's t-test accepting a significance level of P < 0.05.
|
RESULTS |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
, MIP-2, MCP-1, RANTES, and MIP-1 at all time points compared with normoxic controls (Fig. 1A). No induction of CXCL1/keratinocyte-derived chemokine (KC), IL-6, IFN-, or IL-1
was observed in RAW264.7 cells after H/R (data not shown).
|
was observed by MLE-12 cells after H/R (data not shown). In addition, there was no induction of IFN- or IL-1 by MLE-12 cells after H/R at any time point (data not shown). Since the most potent activation of proinflammatory cytokines/chemokines in both RAW264.7 and MLE-12 cells was observed after 3 h of hypoxia and 1 h of reoxygenation, this specific time period was chosen for all subsequent experiments.
H/R induces proinflammatory cytokine/chemokine activation in primary alveolar macrophages and type II epithelial cells.
To confirm that the cytokine/chemokine induction observed in RAW264.7 and MLE-12 cells after H/R is not limited to these immortalized cell lines, primary murine alveolar macrophages and type II epithelial cells were exposed to 3 h of hypoxia and 1 h of reoxygenation. Similar to RAW264.7 cells, H/R-exposed primary alveolar macrophages resulted in significant induction of TNF-, RANTES, MIP-1, MIP-2, and MCP-1 compared with normoxic controls (Fig. 2A). No induction of KC, IL-6, IFN-, or IL-1 was observed in primary alveolar macrophages after H/R (data not shown). Similar to MLE-12 cells, primary alveolar type II cells exhibited a markedly significant increase in the expression of IL-6, MIP-2, RANTES, MCP-1, and KC after H/R (Fig. 2B). No induction of TNF-, IFN-, or IL-1 was observed in primary alveolar epithelial cells after H/R (data not shown).
|
activates type II epithelial cells.
Recombinant TNF- was used to test the hypothesis that MLE-12 cells can be activated by TNF-, a prominent proinflammatory cytokine rapidly produced by alveolar macrophages after IR. Normoxic MLE-12 cells were exposed to recombinant TNF- (1, 5, or 20 ng/ml) for 4 h, and the resultant cytokine/chemokine induction was measured. TNF- significantly induced the activation of MIP-2, IL-6, MCP-1, MIP-1, IL-1, RANTES, and KC in MLE-12 cells compared with unstimulated, normoxic controls (Fig. 3). Significant induction of IL-1, IL-6, RANTES, MIP-2, MCP-1, and KC was also observed in primary alveolar type II epithelial cells after TNF- (20 ng/ml) treatment (Fig. 4). Here we used a dose of 20 ng/ml TNF- because this dose resulted in the highest induction of cytokine expression in MLE-12 cells (Fig. 3).
|
|
from alveolar macrophages modulates the proinflammatory activation of type II epithelial cells.
Since H/R induced TNF- production in alveolar macrophages but not in type II epithelial cells, we then investigated the role of macrophage-derived TNF- in type II cell activation. To do this, we utilized a coculture technique, as described in MATERIALS AND METHODS, in which MLE-12 epithelial cells (preexposed to either 4 h of normoxia or to 3 h/1 h H/R) were cocultured with RAW264.7 macrophages (preexposed to either 4 h of normoxia or to 3 h/1 h H/R) for an additional 4 h. Coculture of normoxic epithelial cells with normoxic macrophages did not induce cytokine/chemokine expression (Fig. 5, A–F, lane 1). Coculture of normoxic epithelial cells with H/R-activated macrophages resulted in significantly augmented induction of IL-6, MCP-1, KC, RANTES, and MIP-2 (lane 3) compared with H/R-activated macrophages alone (Fig. 5, A–E, lane 2). This augmentation in cytokine/chemokine production was prevented by anti-TNF- antibody treatment (Fig. 5, A–E, lane 4). In addition, H/R-activated macrophages significantly augmented cytokine/chemokine production in H/R-activated MLE-12 cells (Fig. 5, A–E, lane 6) compared with HR-activated MLE-12 cells alone (lane 5). This augmentation was also significantly attenuated by anti-TNF- antibody (lane 7). Compared with H/R-activated macrophages alone (lane 2), the level of TNF- expression did not differ after coculture with either normoxic (lane 3) or H/R-activated (lane 6) epithelial cells and was almost completely blocked by anti-TNF- antibody (Fig. 5F, lanes 4 and 7).
|
expression between the H/R-activated epithelial cells alone (lane 3) and the normoxic macrophages cocultured with H/R-activated epithelial cells (lane 2) (Fig. 6). These results suggest that the alveolar macrophages modulate the proinflammatory activation of epithelial cells but not vice-versa.
|
in the mixed cultures, all of which were significantly reduced by anti-TNF--neutralizing antibody (Fig. 7). Interestingly, despite the lower number of cells, the activation of MCP-1 and KC in the mixed cultures (Fig. 7) was fourfold and twofold higher, respectively, than the corresponding activation of the cocultured monolayers (Fig. 5, lane 6). This suggests that cell-cell interaction between macrophages and epithelial cells may augment the induction of certain chemokines after H/R.
|
|
DISCUSSION |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
. The current study demonstrates potent induction of key chemotactic factors such as KC and MIP-2 by type II epithelial cells after H/R, an induction that is significantly augmented by alveolar macrophage-produced TNF-. Hence, the activation of alveolar epithelial cells may provide a vital link between the initial macrophage-dependent response and the subsequent recruitment and activation of circulating neutrophils.
In the present study, we utilized an in vitro model to mimic pulmonary IR injury, by subjecting alveolar macrophages and epithelial cells to acute hypoxia followed by reoxygenation (normoxia). Since Atochina et al. (1) have demonstrated that pulmonary tissue oxygenation can occur through pulmonary vasculature or alveolar oxygen diffusion, lung ischemia may not necessarily lead to tissue anoxia. Hence, our model employed a constant hypoxic condition (5% O2) for all culture experiments. We recognize that a limiting factor with this strategy is that 5% O2 is not anoxia (ischemia), and some may consider this to be mild hypoxia. Nevertheless, we observed very potent cellular responses to acute H/R, responses that are similar to what we observed using an isolated mouse lung model of IR injury (22). The potent proinflammatory response of RAW264.7 and primary alveolar macrophages, specifically secretion of TNF-, points to an initial source of IR injury. More importantly, the activation of alveolar type II cells and release of specific chemokines such as KC, IL-6, MIP-2, and MCP-1 in response to H/R and macrophage-produced TNF- suitably demonstrate that 1) alveolar type II cells are involved in the initial response of acute lung IR injury, 2) this response is at least partially mediated by macrophage-produced TNF-, and 3) specific chemotactic factors released by type II cells may promote the inflammatory cascade by contributing to neutrophil sequestration.
Elevated chemokine expression such as KC, MIP-2, and MCP-1 are an essential event for leukocyte infiltration and accumulation at sites of inflammation, and the potent chemoattractant properties of these chemokines for monocytes (MCP-1), neutrophils (MIP-2, KC), or eosinophils and basophils (RANTES) are well documented (4, 14). Previous studies have shown that IL-1 from alveolar macrophages plays an important role in epithelial cell mediator production in other models of acute lung injury (7). However, in our model we did not observe any induction of IL-1 or IFN- in H/R-induced alveolar macrophages or epithelial cells. This important observation further pinpoints TNF- as a key mediator in the initiation and progression of IR injury. IL-1 has also been postulated to play a role in neutrophil-dependent lung injury (11), and since we did not observe significant IL-1 activation, it further accentuates the role of KC and MIP-2 as important mediators of neutrophil sequestration in IR injury. Although TNF- treatment of primary epithelial cells did induce IL-1 production (Fig. 4), this was quantitatively much smaller than the activation of other cytokines/chemokines.
In a previous study, we observed a significant induction of TNF-, MCP-1, and MIP-2 in an isolated, buffer-perfused mouse model of lung IR injury (22). Here, macrophage depletion prevented the induction of TNF- and MCP-1, whereas MIP-2 expression was only intermediately reduced, thereby suggesting another source of MIP-2 production. The present study suggests that this source could be alveolar type II cells, which not only produce MIP-2 but also KC and MCP-1 in response to either H/R or TNF-. The augmented induction of KC and MCP-1 in the mixed cocultures after H/R (Fig. 7) suggests another possible mechanism involving intercellular interactions in IR injury, i.e., direct contact interaction between alveolar macrophages and epithelial cells. This could be due to added contribution of cell-cell interactive factors such as adhesion molecules (e.g., ICAM-1), surfactant protein production, lipoxin production, nitric oxide, or other cell-cell interactive mediators. In fact, alveolar macrophages and epithelial cells were shown to interact in response to particulate matter, and this interaction is implicated in the enhancement of a variety of proinflammatory cytokines (6).
When comparing the primary cells to the immortalized cell lines, the magnitude of expression was found to be quantitatively different for some cytokines/chemokines (Fig. 1 vs. Fig. 2). For example, RANTES and MIP-1 were induced nearly 10-fold higher in the cell lines, and MCP-1 was induced higher in primary macrophages but lower in primary epithelial cells vs. the corresponding cell lines. These quantitative differences in cytokine/chemokine expression are likely due to inherent characteristic differences between the primary cells and immortalized cells. More importantly, however, the pattern of H/R-induced activation of proinflammatory mediators by primary alveolar macrophages and type II cells was similar to the RAW264.7 and MLE-12 cells, respectively, suggesting that, overall, RAW264.7 and MLE-12 cells are closely representative of the responses of the primary cells.
In summary, the results of this study suggest that alveolar type II cells have an active contribution to acute lung IR injury, which is at least partly in response to alveolar macrophage-produced TNF-, and thus may augment neutrophil recruitment via secretion of chemoattractants such as KC and MIP-2. Although these results suggest that TNF- is a key mediator of acute lung IR injury, TNF- may be only transiently expressed after IR and thus may not be the only mediator important in IR injury mediated by neutrophil activation in sequestration. However, these results support our previous study, which demonstrated that TNF- deficiency, via use of TNF- knockout mice, significantly attenuates acute lung IR injury (12). Importantly, the expression of KC by type II cells appears to be largely dependent on the communication between alveolar macrophages and type II cells via TNF- and not solely on H/R. The dynamic contribution of alveolar type II cells may account for a substantial portion of the pathophysiological events resulting in acute pulmonary IR injury. The elucidation of cell-specific proinflammatory patterns and the resultant cytokine/chemokine activation involving alveolar epithelial cells illustrated in this study, subsequent to conditions of H/R, is novel. The putative signaling mechanisms in alveolar epithelium, involving proinflammatory cytokines/chemokines, transcription factors, and oxidative stress mechanisms, in conjunction with the interaction with other pulmonary cell types, may help delineate the specific targets for future therapeutic intervention strategies.
|
GRANTS |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
|
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|
REFERENCES |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
and TNF- to the initiation of the peripheral lung response to atmospheric particulates (PM10). Am J Physiol Lung Cell Mol Physiol 287: L176–L183, 2004.-Adrenergic blockade restores normal fluid transport capacity of alveolar epithelium after hemorrhagic shock. Am J Physiol Lung Cell Mol Physiol 277: L760–L768, 1999.This article has been cited by other articles:
|
|
 |
|
  M. Cypel, M. Liu, M. Rubacha, J. C. Yeung, S. Hirayama, M. Anraku, M. Sato, J. Medin, B. L. Davidson, M. de Perrot, et al. Functional Repair of Human Donor Lungs by IL-10 Gene Therapy Science Translational Medicine, October 28, 2009; 1(4): 4ra9 - 4ra9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sun, R.-F. Guo, M. W. Newstead, T. J. Standiford, D. R. Macariola, and T. P. Shanley Effect of IL-10 on Neutrophil Recruitment and Survival after Pseudomonas aeruginosa Challenge Am. J. Respir. Cell Mol. Biol., July 1, 2009; 41(1): 76 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yang, A. K. Sharma, J. Linden, I. L. Kron, and V. E. Laubach CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 695 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Yang, A. K. Sharma, M. Marshall, I. L. Kron, and V. E. Laubach NADPH Oxidase in Bone Marrow-Derived Cells Mediates Pulmonary Ischemia-Reperfusion Injury Am. J. Respir. Cell Mol. Biol., March 1, 2009; 40(3): 375 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xu, F. Xu, and E. Barrett Metalloelastase in lungs and alveolar macrophages is modulated by extracellular substance P in mice Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L162 - L170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Elizur, T. L. Adair-Kirk, D. G. Kelley, G. L. Griffin, D. E. deMello, and R. M. Senior Tumor Necrosis Factor-{alpha} from Macrophages Enhances LPS-Induced Clara Cell Expression of Keratinocyte-Derived Chemokine Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 8 - 15. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
